Expansion Sees Q Chip Move to new Facility
News Oct 15, 2008
Q Chip Ltd, a developer of microencapsulation solutions, has officially opened its new corporate headquarters and R&D facility in Cardiff. The expansion into new headquarters marks a significant step in the steady expansion Q Chip has experienced since its foundation.
In summer 2007 Q Chip successfully completed a funding round which saw it raise in excess of £2 million from existing and new shareholders. This investment is being used to expand the product range of ReaX™ encapsulated PCR reagents, Biologix™ microspheres for peptide delivery and cell encapsulation, as well as Q Chip’s proprietary MicroPlant™ microfluidic device.
The MicroPlant produces microspheres of extreme uniformity that encapsulate all the reagents needed to perform a PCR. This means that ReaX assays require minimal user input, time and skill level giving reproducible results.
The MicroPlant production technology also offers significant benefits compared to conventional microencapsulation processes, such as ultra-low wastage, uniform dosing and morphology, and low process costs.
Researchers have developed an artificial enzymatic pathway for synthesizing isoprenoids, or terpenes, in E. coli. This shorter, more efficient, cost-effective and customizable pathway transforms E. coli into a factory that can produce terpenes for use in everything from cancer drugs to biofuels.READ MORE
2nd International Conference on Pharmaceutical Research & Innovations in Pharma Industry
May 30 - May 31, 2019
16th International Conference on Structural Biology
Mar 11 - Mar 12, 2019